Literature DB >> 26847111

Skipping of exon 27 in C3 gene compromises TED domain and results in complete human C3 deficiency.

Karina Ribeiro da Silva1, Tatiana Rodrigues Fraga1, Juliana Faggion Lucatelli1, Anete Sevciovic Grumach2, Lourdes Isaac3.   

Abstract

Primary deficiency of complement C3 is rare and usually associated with increased susceptibility to bacterial infections. In this work, we investigated the molecular basis of complete C3 deficiency in a Brazilian 9-year old female patient with a family history of consanguinity. Hemolytic assays revealed complete lack of complement-mediated hemolytic activity in the patient's serum. While levels of the complement regulatory proteins Factor I, Factor H and Factor B were normal in the patient's and family members' sera, complement C3 levels were undetectable in the patient's serum and were reduced by at least 50% in the sera of the patient's parents and brother. Additionally, no C3 could be observed in the patient's plasma and cell culture supernatants by Western blot. We also observed that patient's skin fibroblasts stimulated with Escherichia coli LPS were unable to secrete C3, which might be accumulated within the cells before being intracellularly degraded. Sequencing analysis of the patient's C3 cDNA revealed a genetic mutation responsible for the complete skipping of exon 27, resulting in the loss of 99 nucleotides (3450-3549) located in the TED domain. Sequencing of the intronic region between the exons 26 and 27 of the C3 gene (nucleotides 6690313-6690961) showed a nucleotide exchange (T→C) at position 6690626 located in a splicing donor site, resulting in the complete skipping of exon 27 in the C3 mRNA.
Copyright © 2016. Published by Elsevier GmbH.

Entities:  

Keywords:  C3 deficiency; Complement system; Exon skipping

Mesh:

Substances:

Year:  2016        PMID: 26847111     DOI: 10.1016/j.imbio.2016.01.005

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  5 in total

Review 1.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

2.  Analysis of Complement C3 Gene Reveals Susceptibility to Severe Preeclampsia.

Authors:  A Inkeri Lokki; Tea Kaartokallio; Ville Holmberg; Päivi Onkamo; Lotta L E Koskinen; Päivi Saavalainen; Seppo Heinonen; Eero Kajantie; Juha Kere; Katja Kivinen; Anneli Pouta; Pia M Villa; Leena Hiltunen; Hannele Laivuori; Seppo Meri
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

3.  A novel approach to immunoapheresis of C3a/C3 and proteomic identification of associates.

Authors:  Wolfgang Winnicki; Peter Pichler; Karl Mechtler; Richard Imre; Ines Steinmacher; Gürkan Sengölge; Daniela Knafl; Georg Beilhack; Ludwig Wagner
Journal:  PeerJ       Date:  2019-12-16       Impact factor: 2.984

4.  Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab.

Authors:  Anna Felberg; Michał Taszner; Aleksandra Urban; Alan Majeranowski; Kinga Jaskuła; Aleksandra Jurkiewicz; Grzegorz Stasiłojć; Anna M Blom; Jan M Zaucha; Marcin Okrój
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

5.  Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals.

Authors:  Emma Ispasanie; Lukas Muri; Anna Schubart; Christine Thorburn; Natasa Zamurovic; Thomas Holbro; Michael Kammüller; Gerd Pluschke
Journal:  Front Immunol       Date:  2021-10-08       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.